120 related articles for article (PubMed ID: 35038444)
1. Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2.
D'Souza MS; Seeley SL; Emerson N; Rose-Malkamaki MJ; Ho SP; Tsai YC; Kuo H; Huan CY; Rorabaugh BR
Pharmacol Biochem Behav; 2022 Feb; 213():173338. PubMed ID: 35038444
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G protein signaling 2 differentially regulates nicotine-induced anxiolytic- and antidepressant-like effects in mice.
Rorabaugh BR; Sprague L; Norman H; Seeley SL; D'Souza MS
Eur J Neurosci; 2018 Sep; 48(5):2110-2117. PubMed ID: 30103281
[TBL] [Abstract][Full Text] [Related]
3. Regulators of G-protein signaling 2 and 4 differentially regulate cocaine-induced rewarding effects.
Rorabaugh BR; Rose MJ; Stoops TS; Stevens AA; Seeley SL; D'Souza MS
Physiol Behav; 2018 Oct; 195():9-19. PubMed ID: 30036561
[TBL] [Abstract][Full Text] [Related]
4. Differential methamphetamine-induced behavioral effects in male and female mice lacking regulator of G Protein signaling 4.
Pham H; Sieg J; Seeley SL; D'Souza MS
Behav Brain Res; 2022 Apr; 423():113770. PubMed ID: 35085702
[TBL] [Abstract][Full Text] [Related]
5. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.
Stratinaki M; Varidaki A; Mitsi V; Ghose S; Magida J; Dias C; Russo SJ; Vialou V; Caldarone BJ; Tamminga CA; Nestler EJ; Zachariou V
Proc Natl Acad Sci U S A; 2013 May; 110(20):8254-9. PubMed ID: 23630294
[TBL] [Abstract][Full Text] [Related]
6. The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.
Dripps IJ; Wang Q; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Psychopharmacology (Berl); 2017 Jan; 234(1):29-39. PubMed ID: 27624599
[TBL] [Abstract][Full Text] [Related]
7. Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells.
Ghil S; McCoy KL; Hepler JR
PLoS One; 2014; 9(4):e95355. PubMed ID: 24743392
[TBL] [Abstract][Full Text] [Related]
8. Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i).
Cladman W; Chidiac P
Mol Pharmacol; 2002 Sep; 62(3):654-9. PubMed ID: 12181442
[TBL] [Abstract][Full Text] [Related]
9. Nicotine enhances the locomotor stimulating but not the conditioned rewarding effect of ethanol in DBA/2J mice.
Gubner NR; Cunningham CL; Phillips TJ
Alcohol Clin Exp Res; 2015 Jan; 39(1):64-72. PubMed ID: 25623407
[TBL] [Abstract][Full Text] [Related]
10. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
Taymans JM; Leysen JE; Langlois X
J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
[TBL] [Abstract][Full Text] [Related]
11. Liver tryptophan 2,3-dioxygenase: a determinant of anxiety-like behaviour - studies with chronic nicotine administration in rats.
Bano S; Sharif H; Sajid F; Hamid SB; Badawy AA
Behav Pharmacol; 2023 Sep; 34(6):307-317. PubMed ID: 37462143
[TBL] [Abstract][Full Text] [Related]
12. The effect of nicotine on antidepressant and anxiolytic responses induced by citalopram and citicoline in mice.
Khakpai F; Zarrindast MR
Acta Neurobiol Exp (Wars); 2023; 83(2):194-202. PubMed ID: 37493535
[TBL] [Abstract][Full Text] [Related]
13. Regulators of G-protein signaling, RGS2 and RGS4, inhibit protease-activated receptor 4-mediated signaling by forming a complex with the receptor and Gα in live cells.
Kim Y; Ghil S
Cell Commun Signal; 2020 Jun; 18(1):86. PubMed ID: 32517689
[TBL] [Abstract][Full Text] [Related]
14. Expression regulation and functional analysis of RGS2 and RGS4 in adipogenic and osteogenic differentiation of human mesenchymal stem cells.
Madrigal A; Tan L; Zhao Y
Biol Res; 2017 Dec; 50(1):43. PubMed ID: 29279050
[TBL] [Abstract][Full Text] [Related]
15. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
Bodenstein J; Sunahara RK; Neubig RR
Mol Pharmacol; 2007 Apr; 71(4):1040-50. PubMed ID: 17220356
[TBL] [Abstract][Full Text] [Related]
16. RGS2 mediates the anxiolytic effect of oxytocin.
Okimoto N; Bosch OJ; Slattery DA; Pflaum K; Matsushita H; Wei FY; Ohmori M; Nishiki T; Ohmori I; Hiramatsu Y; Matsui H; Neumann ID; Tomizawa K
Brain Res; 2012 May; 1453():26-33. PubMed ID: 22459044
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
[TBL] [Abstract][Full Text] [Related]
18. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN
Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576
[TBL] [Abstract][Full Text] [Related]
19. Increased fear learning, spatial learning as well as neophobia in Rgs2
Raab A; Popp S; Lesch KP; Lohse MJ; Fischer M; Deckert J; Hommers L
Genes Brain Behav; 2018 Apr; 17(4):e12420. PubMed ID: 28846187
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant and anxiolytic-like activity of sodium selenite after acute treatment in mice.
Kędzierska E; Dudka J; Poleszak E; Kotlińska JH
Pharmacol Rep; 2017 Apr; 69(2):276-280. PubMed ID: 28167456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
